172@29@16@17!~!172@29@0@53!~!|commonstore|commonfiles|moneycontrol_header.php?cid=0&s_cid=0&radar_off=0&is_revamped_header=0&is_responsive=1&sec=PNC_SHAREHOLDING&priceinter=1&frommc=1!~!www|moneycontrol|com!~!|commonstore|commonfiles|moneycontrol_header.php!~!is_mobile=false
Moneycontrol
SENSEX NIFTY

Pfizer Ltd.

BSE: 500680 | NSE: PFIZER | Series: NA | ISIN: INE182A01018 | SECTOR: Pharmaceuticals

BSE Live

Oct 20, 16:00
4997.55 5.20 (0.10%)
Volume
AVERAGE VOLUME
5-Day
1,237
10-Day
1,751
30-Day
4,977
1,640
  • Prev. Close

    4992.35

  • Open Price

    4993.00

  • Bid Price (Qty.)

    4997.55 (1)

  • Offer Price (Qty.)

    5007.00 (1)

NSE Live

Oct 20, 15:52
5000.85 4.70 (0.09%)
Volume
AVERAGE VOLUME
5-Day
37,159
10-Day
36,055
30-Day
61,747
53,834
  • Prev. Close

    4996.15

  • Open Price

    4996.15

  • Bid Price (Qty.)

    5000.85 (219)

  • Offer Price (Qty.)

    0.00 (0)

Mutual Funds Holding

Stocks attracting Fund Managers
Pfizer traded by Mutual Fund Schemes
Check out MF Action in another Stock:
Go
Scheme Name Sep '20 Jun '20 Mar '20 Dec '19 Sep '19 Jun '19
  AUM
(Rs. cr.)
No. of share % No. of share No. of share No. of share No. of share No. of share
ABSL Dividend Yield Fund (G) - - - 38,563 - - 46,924 48,875
ABSL Dividend Yield Fund - D (G) - - - 2,227 - - 2,414 2,427
ABSL Equity Hybrid '95 Fund (G) - - - 288,181 - - 444,201 453,932
ABSL Equity Hybrid '95 Fund - D (G) - - - 29,357 - - 44,037 43,234
ABSL Equity Savings Fund-DP (G) - - - 1,320 - - 5,447 5,806
ABSL Equity Savings Fund-RP (G) - - - 16,564 - - 52,468 60,264
ABSL Midcap Fund (G) - - - 98,109 - - 186,197 178,263
ABSL Midcap Fund -Direct (G) - - - 10,281 - - 18,814 20,655
ABSL MNC Fund (G) - - - 624,573 - - 809,758 867,018
ABSL MNC Fund -Direct (G) - - - 72,834 - - 89,018 93,116
ABSL Tax Plan (G) - - - 74,824 - - 85,787 99,175
ABSL Tax Plan-Direct (G) - - - 10,112 - - 11,137 12,626
ABSL Tax Relief '96 (G) - - - 1,381,955 - - 1,303,525 1,315,249
ABSL Tax Relief '96-Direct (G) - - - 281,553 - - 235,121 227,735
BOI Large & Mid Cap Equity - D (G) - - - - - - 1,174 762
BOI Large & Mid Cap Equity - R (G) - - - - - - 7,438 5,101
BOI Large & Mid Cap Equity-E (G) - - - - - - 161 118
IDBI Long Term Value-DP (G) - - - - - - - 180
IDBI Long Term Value-RP (G) - - - - - - - 9,918
Kotak Balanced Advantage - Dir. (G) 198.88 1,786 0.44% 1,580 - - - 952
Kotak Balanced Advantage - Reg. (G) 3,984.09 35,778 0.44% 35,838 - - - 42,313
Kotak Bluechip Fund (G) 1,339.82 24,604 0.90% 22,446 - - - 33,437
Kotak Bluechip Fund - D (G) 301.21 5,531 0.90% 5,240 - - - 6,591
L&T India Large Cap - Direct (G) - - - - - - - 500
L&T India Large Cap Fund (G) - - - - - - - 4,327
Mahindra Manulife ELSS Kar Bachat - DP ( - - - - - - 354 370
Mahindra Manulife ELSS Kar Bachat - RP ( - - - - - - 18,367 19,277
Motilal MOSt Oswal Midcap 100 ETF - - - 918 - 729 - 564
PGIM India Diversified Equity-DP (G) - - - - - - - 103
PGIM India Diversified Equity-RP (G) - - - - - - - 3,774
SBI Contra Fund (G) - - - 43,238 - 68,723 68,393 71,107
SBI Contra Fund - Direct (G) - - - 2,105 - 3,135 3,045 2,965
SBI Healthcare Opportunities (G) - - - 42,595 - 60,842 9,040 -
SBI Healthcare Opportunities - D (G) - - - 14,477 - 18,333 4,915 -
SBI Magnum Global Fund (G) - - - 177,934 - 188,557 172,523 187,262
SBI Magnum Global Fund - Direct (G) - - - 16,898 - 17,982 17,811 19,244
Taurus Discovery (Midcap) (G) - - - - - - 1,999 -
Taurus Discovery (Midcap) - D (G) - - - - - - 28 -
Taurus Ethical Fund (G) - - - - - - 1,160 -
Taurus Ethical Fund - Direct (G) - - - - - - 170 -
Taurus Starshare MCF (G) - - - - - - 9,573 3,969
Taurus Starshare MCF - D (G) - - - - - - 193 69
Taurus Tax Shield (G) - - - - - - 1,890 -
Taurus Tax Shield - Direct (G) - - - - - - 534 -
UTI CCF - Savings Plan - DP - - - - - - - 5,005
UTI CCF - Savings Plan - RP - - - - - - - 131,857
UTI Healthcare Fund (G) - - - - - - - 52,576
UTI Healthcare Fund - D (G) - - - - - - - 7,262
Total - 67,699 - 3,293,722 0 358,301 3,653,616 4,037,978
Scheme Name Sep '20 Jun '20
  Asset (Rs. cr.) No. of share % No. of share
Kotak Balanced Advantage - Dir. (G) 198.88 1,786 0.44% 1,580
Kotak Bluechip Fund (G) 1,339.82 24,604 0.90% 22,446
Kotak Bluechip Fund - D (G) 301.21 5,531 0.90% 5,240
Total 0 0
Scheme Name Sep '20 Jun '20
  Asset (Rs. cr.) No. of share % No. of share
ABSL Dividend Yield Fund (G) - - - 38,563
ABSL Dividend Yield Fund - D (G) - - - 2,227
ABSL Equity Hybrid '95 Fund (G) - - - 288,181
ABSL Equity Hybrid '95 Fund - D (G) - - - 29,357
ABSL Equity Savings Fund-DP (G) - - - 1,320
ABSL Equity Savings Fund-RP (G) - - - 16,564
ABSL Midcap Fund (G) - - - 98,109
ABSL Midcap Fund -Direct (G) - - - 10,281
ABSL MNC Fund (G) - - - 624,573
ABSL MNC Fund -Direct (G) - - - 72,834
ABSL Tax Plan (G) - - - 74,824
ABSL Tax Plan-Direct (G) - - - 10,112
ABSL Tax Relief '96 (G) - - - 1,381,955
ABSL Tax Relief '96-Direct (G) - - - 281,553
Kotak Balanced Advantage - Reg. (G) 3,984.09 35,778 0.44% 35,838
Motilal MOSt Oswal Midcap 100 ETF - - - 918
SBI Contra Fund (G) - - - 43,238
SBI Contra Fund - Direct (G) - - - 2,105
SBI Healthcare Opportunities (G) - - - 42,595
SBI Healthcare Opportunities - D (G) - - - 14,477
SBI Magnum Global Fund (G) - - - 177,934
SBI Magnum Global Fund - Direct (G) - - - 16,898
Total 3 35778 0.44 3264456
Scheme Name Sep '20 Jun '20
  Asset (Rs. cr.) No. of share % No. of share

Note :

* For schemes that have not disclosed the number of shares, the same has been calculated on the basis of the closing price of the stock on the BSE/NSE as on the portfolio date. The increase/decrease in the share quantity besides the fund buying or selling the shares from the market, could also be due to any bonus, split, rights, or restructuring in the company.
** The numbers in green / red indicate increase /decrease, respectively in the no. of shares over the shares mentioned in the previous month.

PLEASE NOTE :

This report is based on the quarter-end portfolios disclosed by AMCs (mutual funds). Starting October 2010, select AMCs have stopped declaring monthly AUM (Assets under Management) and value of the stock in their Portfolio, hence the number of shares for the schemes from these AMCs could not be incorporated in the above report. For Sep '19, it displays data for 18 out of the total 45 AMCs.